Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

La-Z-Boy Incorporated Common Stock (NY: LZB )

44.86 -0.29 (-0.64%)
Official Closing Price Updated: 7:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about La-Z-Boy Incorporated Common Stock

< Previous 1 2 3 4 5 Next >
Nvidia, La-Z-Boy And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
How To Earn $500 A Month From La-Z-Boy Stock Ahead Of Q3 Earnings Results
La-Z-Boy Incorporated (NYSE: LZB) is expected to release earnings results for its third quarter fiscal 2024, after the closing bell on Feb. 20, 2024. 
Via Benzinga
US Stocks Set For Weaker Open On Mixed Retail Earnings, But Analyst Shrugs Off Weakness As 'Scary Moments' In Great Years
The market is entering a typically soft period and inflation worries have weighed on sentiment this time around. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Preview For La-Z-Boy
Via Benzinga
Why LA-Z-BOY INC (NYSE:LZB) should be investigated by quality investors.
LA-Z-BOY INC (NYSE:LZB) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
La-Z-Boy's Ex-Dividend Date Is Tuesday, Here's What You Need To Know
Via Benzinga
Earnings Outlook For La-Z-Boy
Via Benzinga
La-Z-Boy Earnings Perspective: Return On Invested Capital
Via Benzinga
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Why La-Z-Boy Stock Is Moving Today
La-Z-Boy Incorporated (NYSE: LZB) shares are trading higher on Thursday after the company reported better-than-expected second-quarter financial results, issued third-quarter guidance and boosted its 
Via Benzinga
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. 
Via Benzinga
Topics Stocks
Exposures US Equities
Kroger, Dell And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Earnings Scheduled For November 29, 2023
Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per share on revenue of $3.50 million. 
Via Benzinga
Why La-Z-Boy Stock Jumped 14% This Past Week
CEO Melinda Whittington sees a path to increased market share. 
Via The Motley Fool
HP, Roblox And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 0.2% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
US Stocks Set To Extend Rally As Fed Speeches, Nvidia Q2 Print Loom: Analyst Says 'Don't Panic' As Pullback Presents Buying Opportunity
After the lean patch seen last week, the stock market seems to have picked up momentum, riding on the hopes of a Fed pause. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Earnings Scheduled For August 22, 2023
Companies Reporting Before The Bell • BHP Group (NYSE:BHP) is estimated to report earnings for its Fiscal Year 2023. 
Via Benzinga
Why La-Z-Boy Shares Are Booming Today
La-Z-Boy Inc. (NYSE: LZB) shares are trading higher on Wednesday after the company reported better-than-expected third-quarter results. 
Via Benzinga
La-Z-Boy Gets A Handle On Your Social Life With Its AI-Powered Excuse Generator, 'The Decliner'
Via Benzinga
Overview Of Value Stocks In The Consumer Cyclical Sector
Via Benzinga
La-Z-Boy Stock Getting Closer To Key Technical Benchmark
La-Z-Boy stock saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 69 to 79. 
Via Investor's Business Daily
US Stocks Poised For Nervous Start As Fed Chair Powell Heads To Capitol Hill
Via Benzinga
La-Z-Boy, FedEx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. Zura Bio Limited (NASDAQ: ZURA) shares tumbled 7.7% to $11.82 in... 
Via Benzinga
Winnebago Industries, La-Z-Boy And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
US Stock Futures Pull Back As Focus Turns To Fed Speeches, Powell's Testimony: Why This Analyst Says Brace For Above-Average Returns
Via Benzinga
FedEx, Alibaba And 3 Stocks To Watch Heading Into Tuesday
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Investor Sentiment Declines Slightly After Dow Drops Over 100 Points
The CNN Money Fear and Greed index showed a slight decline in overall sentiment among U.S. investors on Friday. U.S. stocks closed lower on Friday, with the S&P 500 breaking its six-session win streak.... 
Via Benzinga
Luxury Furnishing Retailer RH Stock Earns IBD Rating Upgrade
The Relative Strength (RS) Rating for RH stock climbed into a higher percentile Friday, as it got a lift from 70 to 77. 
Via Investor's Business Daily
La-Z-Boy Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
On Thursday, La-Z-Boy stock saw a positive improvement to its Relative Strength (RS) Rating, rising to 90 from 77 a day earlier. 
Via Investor's Business Daily
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.